PF-03882845

DRUG2 trials

Sponsors

Pfizer

Conditions

Diabetes Mellitus, Type 2Type 2 Diabetic Nephropathy

Phase 1

A Study Of PF-03882845 Absorption In Healthy Volunteers Given Orally As Tablet Versus Suspension Formulations And Effect Of Food On Its Absorption

CompletedNCT01366287

PfizerDiabetes Mellitus, Type 2

Start: 2011-01-31End: 2011-02-28Updated: 2011-06-06

A Study To Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy

TerminatedNCT01488877

PfizerType 2 Diabetic Nephropathy

Start: 2012-01-31End: 2012-07-31Updated: 2013-10-29